OCDX
NASDAQOrtho Clinical Diagnostics Holdings plc
Website
News25/Ratings8
Latest news
25 items- SECSEC Form 15-12B filed by Ortho Clinical Diagnostics Holdings plc15-12B - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- INSIDERSEC Form 4: Iskra Michael S. returned 150,000 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4 filed by Busky Joseph M4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Schlesinger Michael A. returned 87,637 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4 filed by Palaniappan Chockalingam4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Yates Robert Clifton returned 323,880 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Smith Christopher M returned 367,360 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Dilsaver Evelyn S returned 5,200 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Mac Mahon Thomas P returned 141,853 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Labrum Ronald K returned 109,985 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Hull Carl returned 62,183 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Perez David Brian returned 8,576 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Bechtel Karen returned 5,200 units of Ordinary Shares to the company, closing all direct ownership in the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- INSIDERSEC Form 4: Carlyle Group Inc. returned 118,106,000 units of Ordinary Shares to the company4 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Issuer)
- SECOrtho Clinical Diagnostics Holdings plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- SECSEC Form 25-NSE filed by Ortho Clinical Diagnostics Holdings plc25-NSE - Ortho Clinical Diagnostics Holdings plc (0001828443) (Subject)
- SECOrtho Clinical Diagnostics Holdings plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- PRQuidel and Ortho Announce Expected Closing of Ortho TransactionSAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ:QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings plc ("Ortho"), one of the world's larger pure-play in vitro diagnostics companies, announced today that the closing of the previously announced Ortho transaction is expected to occur on May 27, 2022. On May 26, 2022, the High Court of Justice of England and Wales issued an order under Part 26 of the UK Companies Act sanctioning the scheme of arrangement to be undertaken by Ortho in connection with the business combinations (the "Ortho Scheme Order")
- PRQuidel and Ortho Announce Expected Closing of Ortho TransactionQuidel Corporation (NASDAQ:QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings plc ("Ortho"), one of the world's larger pure-play in vitro diagnostics companies, announced today that the closing of the previously announced Ortho transaction is expected to occur on May 27, 2022. On May 26, 2022, the High Court of Justice of England and Wales issued an order under Part 26 of the UK Companies Act sanctioning the scheme of arrangement to be undertaken by Ortho in connection with the business combinations (the "Ortho Scheme Order"). The order will become effective once the Or
- SECOrtho Clinical Diagnostics Holdings plc filed SEC Form 8-K: Regulation FD Disclosure8-K - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- SECOrtho Clinical Diagnostics Holdings plc filed SEC Form 8-K: Other Events, Submission of Matters to a Vote of Security Holders (Amendment)8-K/A - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- SECOrtho Clinical Diagnostics Holdings plc filed SEC Form 8-K: Regulation FD Disclosure (Amendment)8-K/A - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- SECOrtho Clinical Diagnostics Holdings plc filed SEC Form 8-K: Regulation FD Disclosure8-K - Ortho Clinical Diagnostics Holdings plc (0001828443) (Filer)
- PROrtho Clinical Diagnostics Shareholders Approve Quidel TransactionRARITAN, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) ("Ortho" or the "Company"), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced that based on a preliminary vote count by its proxy solicitor, Ortho shareholders have voted to approve the combination of the Company with Quidel Corporation (NASDAQ:QDEL) ("Quidel") pursuant to the Business Combination Agreement, dated December 22, 2021, by and among the Company, Quidel, and the other parties thereto (the "BCA"). The closing of the transactions contemplated by the BCA is subject to sanction of the combination by the High Court of Justice of England and W
- SECSEC Form 425 filed by Ortho Clinical Diagnostics Holdings plc425 - Ortho Clinical Diagnostics Holdings plc (0001828443) (Subject)